HOME >> BIOLOGY >> NEWS
Joslin study indicates insulin receptors play a critical role in promoting islet growth

BOSTON -- April 2, 2007 -- A new Joslin-led study has identified the insulin receptor as an important protein that promotes islet cell growth in mice whose bodies are unable to use insulin properly, or are insulin resistant, a precursor to type 2 diabetes. Since the body's natural response to insulin resistance is to increase insulin secretion from the pancreas and grow more islet cells, also known as beta cells, harnessing this growth response could lead to new treatments for type 2 diabetes. The study appears in the early online edition of this week's Proceedings of the National Academy of Sciences.

"The failure to grow more functional beta cells (also called compensatory islet cell growth response) leads to overt diabetes," said Rohit N. Kulkarni, M.D., Ph.D., Investigator at Joslin Diabetes Center and Assistant Professor of Medicine at Harvard Medical School, who led the study. "If we can identify the key signaling proteins critical for the islet cell growth response, we can develop potential therapeutic targets to enhance the growth of beta cells."

There are two proteins that mediate the effects of growth factors in beta cells, the insulin-producing cells in the pancreas: insulin receptor, a protein that mediates the action of insulin, and IGF-1 receptor, another protein that closely resembles the insulin receptor and mediates the action of insulin-like-growth factor (IGF-I), a hormone and growth factor. These two receptors have been a major focus of research studies by Dr. Kulkarni and others at Joslin Diabetes Center who want to better understand beta cell growth and functioning so that these essential cells can be increased in people with diabetes.

In type 2 diabetes, the body doesn't produce enough insulin and/or is unable to use insulin properly (insulin resistance). This form of diabetes usually occurs in people who are over 40, overweight, and have a family history of diabetes, although today it is increasingly occurring
'"/>

Contact: Jenny Eriksen
jenny.eriksen@joslin.harvard.edu
617-732-2415
Joslin Diabetes Center
2-Apr-2007


Page: 1 2 3

Related biology news :

1. Joslin researchers discover a surprising culprit in the search for causes of diabetic birth defects
2. Joslin study reveals how a specific fat type can protect against weight gain and diabetes
3. Joslin discovers protein that causes blood vessel leakage and swelling with diabetic retinopathy
4. Joslin-led study uncovers role of appetite hormone MCH in insulin production
5. Joslin Diabetes Center study examines insulin pump therapy in adolescents
6. Joslin Diabetes Center in Boston establishes first affiliate in Canada
7. Walgreens and Joslin Diabetes Center form broad alliance to improve diabetes outcomes
8. Joslin awards Victory Medal to New York man living 75 years with type 1 diabetes
9. Joslins new book demystifies nutrition and meal planning for people with diabetes
10. Joslin study refutes recent report that bone marrow can replenish female oocytes
11. Joslin discovers signs of residual islet cell function in people with long-term type 1 diabetes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/28/2020)... ... June 25, 2020 , ... ... today announced that it has entered into a multi-year contract with Merus ... support their translational and clinical research strategy to discover and develop ground-breaking ...
(Date:6/25/2020)... ... June 24, 2020 , ... ... software-driven clinical data services that accelerate drug development, is collaborating with Karyopharm Therapeutics ... inhibitor, in hospitalized patients with severe COVID-19. This is the first study of ...
(Date:6/23/2020)... MILTON KEYNES, England (PRWEB) , ... June 23, ... ... operations in Africa supporting sustainable healthcare, and Renovagen Ltd, a UK supplier and ... rapid response project to support testing operations in the fight against the COVID-19 ...
Breaking Biology News(10 mins):
(Date:5/21/2020)... ... May 19, 2020 , ... Experienced periodontist in Eden Prairie, MN, Dr. Andres ... grafting through PIEZOSURGERY® technology. PIEZOSURGERY uses ultrasonic vibrations to gently cut bone ... patient for dental implants, especially when the implants need to be placed in a ...
(Date:5/21/2020)... ... 20, 2020 , ... Exo (pronounced “Echo”) is ... company’s executive vice president of product engineering and report directly to CEO Sandeep ... space, bringing more than 24 years of technology leadership experience from Google, Apple, ...
(Date:5/15/2020)... , ... May 14, 2020 , ... ... undergo multiple open heart surgeries before becoming adults. The reason: there ... To address this critical unmet need, the Department of Defense has awarded Draper, ...
(Date:5/15/2020)... ... May 15, 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology company developing ... Chairman. Mr. Ganz will continue to lead Sentien’s Board of Directors, a role ... CEO Brian Miller and Sentien’s management team. , Mr. Ganz has more ...
Breaking Biology Technology:
Cached News: